Navigation Links
Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
Date:5/29/2008

ements. Factors that might cause such a difference include, but are not limited to: the Company's ability to hire and transition to a new Chief Financial Officer, the Company's ability to continue to develop and expand its diagnostic services business, the Company's ability to expand and maintain a successful sales and marketing organization, the Company's ability to maintain compliance with financial and other covenants under its credit facilities, the effects of a going concern audit opinion on the Company's operations, the Company's ability to successfully transition its billing function in-house from a third party vendor, the Company's ability to successfully complete a joint development agreement with Zeiss for the development of novel diagnostic tests, whether the conditions to payment of all or any portion of the contingent consideration from the Company's sale of its instrument systems business to Zeiss are satisfied, the Company's ability to remediate the material weaknesses in the Company's internal control over financial reporting, the Company's ability to successfully transition its customer billings from a third party billing vendor to an in-house billing system, the continuation of favorable third party payer reimbursement for laboratory tests, the Company's ability to obtain additional financing on acceptable terms or at all, unanticipated expenses or liabilities or other adverse events affecting cash flow, uncertainty of success in identifying and developing new diagnostic tests or novel markers, the Company's ability to fund development of new diagnostic tests and novel markers and the amount of resources the Company determines to apply to novel marker development and commercialization, the Company's ability to obtain additional financing if required on favorable terms or at all, failure to obtain FDA clearance or approval for particular applications, the Company's ability to compete with other technologies and with emerging competitors in novel can
'/>"/>
SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Jim Agnello to Resign as Clarient Chief Financial Officer
2. Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Clarient to Commercialize Novel Breast Cancer Profile
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. Abt Associates Names Richard Small Vice President and Chief Financial Officer
7. Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
8. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
9. Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board
10. RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner
11. Codexis Names David Anton VP Bioindustrials R&D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... Ill. , July 18, 2014 /PRNewswire/ ... infographic highlighting AbbVie and Shire,s complementary fit ... A copy of the infographic ... at:  http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents In ... Code, a copy of this announcement will ...
(Date:7/18/2014)... Switzerland , July 18, 2014 ... Education in Animal Research for the third consecutive year. ... State University, will attend a 1-week course at Zürich ... of the 3Rs (Replace, Reduce, Refine). As head of ... Popov has been given the task of adapting experimental ...
(Date:7/17/2014)... July 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the development and commercialization of products for the treatment ... release results for the second quarter of 2014 on ... The Company will host a conference call ... during which Vanda management will discuss the second quarter ...
(Date:7/17/2014)... Australia , July 17, 2014  Prana Biotechnology ... provided an update on its clinical development program for ... the Florey Institute of Neuroscience and Mental Health, The ... Phase 2 IMAGINE and EURO trials in his presentation ... Copenhagen, Denmark . The presentation is ...
Breaking Biology Technology:NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 2NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 3NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 4NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 5NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 6NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 7Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research" 2Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5
... 17 Repligen Corporation,(Nasdaq: RGEN ) announced today ... Herlihy, Ph.D., will present at the 2008 UBS,Global Life ... EDT at the Grand Hyatt Hotel, 455 Madison Avenue, ... presentation will be available via,Repligen,s website at http://www.repligen.com ...
... 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, today announced that its ... CA, will present a,company overview at the upcoming ... Tuesday, September 23, 2008 at 3:25 pm (eastern,time), ...
... Coast Oncology to be the first private practice in ... offer state-of-the-art proton radiation ... M.D.,Medical Director, First Coast Oncology, Jacksonville, FL is pleased ... Monarch250(TM),Proton Therapy System from Still River Systems, Inc, in ...
Cached Biology Technology:Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 2Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 3First Coast Oncology to Offer Next Generation Proton Therapy 2First Coast Oncology to Offer Next Generation Proton Therapy 3
(Date:7/21/2014)... hotspots in areas across Riau province on Sunday, July ... following a decline in rainfall. The number of ... what had been reported one day prior, which had ... in six regencies and municipalities, most of which were ... haze it creates could potentially spread via winds to ...
(Date:7/21/2014)... to climate change, due to greenhouse gasses emitted by ... the rise and that beef cattle are responsible for ... animals. It is published by Climactic Change . ... it comes to climate change. It is released by ... portion of greenhouse gas totals. But methane and nitrous ...
(Date:7/21/2014)... causing problems for the world,s water sources. In ... stormwater runoff to be one of the top ... lakes, ponds, reservoirs, bays, and estuaries. The pollutants ... wildlife populations, foul drinking water, and make recreational ... University are looking to rain gardens as one ...
Breaking Biology News(10 mins):Climate: Meat turns up the heat 2Filter bed substrates, plant types recommended for rain gardens 2
... plants ship sugars from their leaves to flowers, roots, ... engineering techniques, Cornell researchers have finally proven a long-standing ... deepen understanding of basic plant biology but could one ... photosynthetic rates, yields and carbon dioxide intake. This might ...
... to better understand the relationship between the bacteria ... defense cells that engulf them., The researchers have ... tuberculosis does not react when immune system ... bacterium,s genes become activated minutes after the pathogen ...
... winners of its student travel award to attend the ... Biophysics Congress in Long Beach, California, February 2-6, 2008. ... on scientific merit, with priority given to those who ... awardee receives a travel grant and will be recognized ...
Cached Biology News:Cornell researchers prove how plants transport sugars 2Cornell researcher seeks clues to how tuberculosis infects cells 2Biophysical Society announces winners of 2008 Student Travel Awards 2Biophysical Society announces winners of 2008 Student Travel Awards 3Biophysical Society announces winners of 2008 Student Travel Awards 4Biophysical Society announces winners of 2008 Student Travel Awards 5
... The thermostable dUTPase(pyrococcus fruriosus) maximizes the ... DNA polymerases). It removes contaminating ... dNTP solutions. The presence of ... reaction can prevent dUTP misincorporation by ...
... comes with a shutter (controlled via a TTL ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ... lamp provides peak-to-peak stability of less than 0.005% ...
... The NOVOstar is an exciting product for ... cell-based assays required the use of expensive ... for scientists in the assay development stage. ... for cell-based assays as well as any ...
... intactness and detects events that dissipate ... Benefits: Fast, simple, and ... and for assaying mitochondria intactness ... for the detection of changes in ...
Biology Products: